Decalcification of the Aortic Valve by Vitamin K2 (Menaquinone-7)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT03305536
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT03305536
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Lebanon
- Registry status
- Unknown status
Technical summary
Registry record NCT03305536. Randomized; quadruple masking; primary purpose treatment. Start 2018-01-02 (actual); primary completion 2020-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Decalcification of the Aortic Valve by Vitamin K2 (Menaquinone-7)
- Acronym
- DECAV-K2
- Condition
- Aortic Valve Disease
- Intervention (Dietary supplement)
- Vitamin K2 (Menaquinone 7) + Vitamin D3
- Lead sponsor
- Hopital St. Georges, Ajaltoun
- Collaborator
- Omicron Pharmaceuticals
- Collaborator
- Nattopharma ASA
Record details
- Record id
cardio:ct-nct03305536- Content hash
9c1eee7c46ad5c1dcaca113f97848ba5716f7dfdd2ec1e611bea0751a1eaaf9f